Assessment of the redox profile and oxidative DNA damage (8-OHdG) in squamous cell carcinoma of head and neck

Journal of Cancer Research and Therapeutics

Volumn 8, Issue 2, 2012, Pages 254-259

  Kumar, Anil ^a   Pant, Mohan C ^b   Singh, Hirdya S ^c   Khandelwal, Shashi ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b UNIVERSITY OF LUCKNOW   (India)

^c CH CHARAN SINGH UNIVERSITY   (India)

Author keywords

8 OHdG; reactive nitrogen species; reactive oxygen species; squamous cell carcinoma of head and neck; total antioxidant capacity

Indexed keywords

DNA; FREE RADICAL; GLUTATHIONE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER PATIENT; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MASTICATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; SQUAMOUS CELL CARCINOMA; TOBACCO;

ADULT; AGED; ANTIOXIDANTS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DEOXYGUANOSINE; DNA DAMAGE; GLUTATHIONE; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; YOUNG ADULT;

EID: 84864693108     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.98980     Document Type: Article

References (43)

1. Halliwell B, Gutteridge JM. Free radicals in biology and medicine. 4th ed. New York: Oxford University Press; 1999.
2. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, et al. Oxidants in mitochondria: From physiology to diseases. Biochim Biophys Acta 1995;1271:67-74.
3. Halliwell B. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence? Lancet 1994;344:721-4.
4. Kuchino Y, Mori F, Kasai H, Inoue H, Iwai S, Miura K, et al. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 1987;327:77-9.
5. Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991;349:431-4.
6. Kasai H, Yamaizumi Z, Yamamoto F, Bessho T, Nishimura S, Berger M, et al. Photosensitized formation of 8-hydroxyguanine (7,8-dihydro- 8-oxoguanine) in DNA by riboflavin. Nucleic Acids Symp Ser 1992;(27):181-2.
7. Trottier H, Burchell AN. Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics 2009;12:291-307.
8. Warnakulasuriya S. Causes of oral cancer-an appraisal of controversies. Br Dent J 2009;207:471-5.
9. McLaughlin-Drubin ME, Münger K. Oncogenic activities of human papillomaviruses. Virus Res 2009;143:195-208.
10. Meister A, Larsson A. Glutathione synthetase deficiency and other disorders of the g-glutamyl cycle. In: Larsson A, editor. The metabolic bases of inhe. 6th ed. New York: McGraw-Hill; 1989. p. 855-68.
11. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: Implication in redox and detoxification. Clin Chim Acta 2003;333: 19-39.
12. Patel JB, Shah FD, Shukla SN, Shah PM, Patel PS. Role of nitric oxide and antioxidant enzymes in the pathogenesis of oral cancer. J Cancer Res Ther 2009;5:247-53.
13. Bhagat SS, Ghone RA, Suryakar AN, Hundekar PS. Lipid peroxidation and antioxidant vitamin status in colorectal cancer patients. Indian J Physiol Pharmacol 2011;55:72-6.
14. Battisti V, Maders LD, Bagatini MD, Reetz LG, Chiesa J, Battisti IE, et al. Oxidative stress and antioxidant status in prostate cancer patients: Relation to Gleason score, treatment and bone metastasis. Biomed Pharmacother 2011;65:516-24.
15. Quiñones L, Lucas D, Godoy J, Cáceres D, Berthou F, Varela N, et al. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 2001;174:35-44.
16. Sikdar N, Mahmud SA, Paul RR, Roy B. Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett 2003;195:33-42.
17. Richard wB, Armstrong D. Reduced Glutathione and Glutathione Disulfide. New Jersey: Humana Press; 1998.
18. LeBel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2?,7?-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992;5:227-31.
19. Possel H, Noack H, Augustin W, Keilhoff G, Wolf G. 2,7- Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation. FEBS Lett 1997;416:175-8.
20. Cathcart R, Schwiers E, Ames BN. Detection of picomole levels of lipid hydroperoxides using a dichlorofluorescein fluorescent assay. Methods Enzymol 1984;105:352-8.
21. Hensley K, Mou S, Quentin PN. Nitrite determination by colorometric and fluorometric griess diazotiztion assays. Totowa New Jersy: Humana press; 2003.
22. Zhang J, Perry G, Smith MA, Robertson D, Olson SJ, Graham DG, et al. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol 1999;154:1423-9.
23. Arioz DT, Camuzcuoglu H, Toy H, Kurt S, Celik H, Aksoy N. Serum prolidase activity and oxidative status in patients with stage I endometrial cancer. Int J Gynecol Cancer 2009;19:1244-7.
24. Seven A, Civelek S, Inci E, Inci F, Korkut N, BurÇak G. Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clin Biochem 1999;32:369-73.
25. Beevi SS, Rasheed AM, Geetha A. Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol 2004;34:379-85.
26. Brodská B, Holoubek A. Generation of reactive oxygen species during apoptosis induced by DNA-damaging agents and/or histone deacetylase inhibitors. Oxid Med Cell Longev 2011;2011:253529.
27. Jaiswal M, LaRusso NF, Nishioka N, Nakabeppu Y, Gores GJ. Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide. Cancer Res 2001;61:6388-93.
28. Van Wijk R, Van Wijk EP, Wiegant FA, Ives J. Free radicals and low-level photon emission in human pathogenesis: State of the art. Indian J Exp Biol 2008;46:273-309.
29. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J 1996;313:17-29.
30. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004;266:37-56.
31. Klaunig J, Kamendulis L, Hocevar B. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 2010;38:96-109.
32. Lander HM, Ogiste JS, Teng KK, Novogrodsky A. p21ras as a common signaling target of reactive free radicals and cellular redox stress. J Biol Chem 1995;270:21195-8.
33. Cerutti PA, Trump BF. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 1991;3:1-7.
34. Tudek B, Winczura A, Janik J, Siomek A, Foksinski M, Olinski R. Involvement of oxidatively damaged DNA and repair in cancer development and aging. Am J Transl Res 2010;2:254-84.
35. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-8.
36. Farias JW, Furtado FS, Guimarães SB, Silva Filho AR, Vasconcelos PR. Oxidative stress parameters in women with breast cancer undergoing neoadjuvant chemotherapy and treated with nutraceutical doses of oral glutamine. Acta Cir Bras 2011;26(Suppl 1):82-7.
37. Hatam N, Ahmadloo N, Ahmad Kia Daliri A, Bastani P, Askarian M. Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil). Arch Gynecol Obstet 2011;284:215-20.
38. Korde SD, Basak A, Chaudhary M, Goyal M, Vagga A. Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma. Oncology 2011;80:382-9.
39. Panis C, Herrera AC, Victorino VJ, Campos FC, Freitas LF, De Rossi T, et al. Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat 2012;133:89-97.
40. Vieira FG, Di Pietro PF, Boaventura BC, Ambrosi C, Rockenbach G, Fausto MA, et al. Factors associated with oxidative stress in women with breast cancer. Nutr Hosp 2011;26:528-36.
41. Sharma M, Rajappa M, Kumar G, Sharma A. Oxidant-antioxidant status in Indian patients with carcinoma of posterior one-third of tongue. Cancer Biomark 2009;5:253-60.
42. Mulder TP, Manni JJ, Roelofs HM, Peters WH, Wiersma A. Glutathione S-transferases and glutathione in human head and neck cancer. Carcinogenesis 1995;16:619-24.
43. Wong DY, Hsiao YL, Poon CK, Kwan PC, Chao SY, Chou ST, et al. Glutathione concentration in oral cancer tissues. Cancer Lett 1994;81:111-6.